Vedolizumab prophylaxis against postoperative Crohn's disease recurrence. Mulligan RJ, Lamb CA. Lancet Gastroenterol Hepatol 2024 Nov 18:S2468-1253(24)00352.

Read + Share

Amedeo Smart

Independent Medical Education

Mulligan RJ, Lamb CA. Vedolizumab prophylaxis against postoperative Crohn's disease recurrence. Lancet Gastroenterol Hepatol 2024 Nov 18:S2468-1253(24)00352.
PMID: 39571586